Condition: Actinic Keratoses · Sponsor: Encube Ethicals Pvt. Ltd.
Fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| CBCC Global Research Site 005 | Bakersfield, California, United States | — |
| CBCC Global Research Site 006 | Cerritos, California, United States | — |
| CBCC Global Research Site 004 | Lauderdale Lakes, Florida, United States | — |
| CBCC Global Research Site 001 | Miami, Florida, United States | — |
| CBCC Global Research Site 002 | Miami, Florida, United States | — |
| CBCC Global Research Site 003 | Miramar, Florida, United States | — |
| CBCC Global Research Site 007 | Sugarloaf, Pennsylvania, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05078827